BacTech Provides Capital Structure Update



BacTech also reports that a total of 2,879,500 common share purchase warrants were exercised recently adding an additional $143,975 to the treasury.

BacTech also issued common share purchase warrants to certain individuals who previously agreed to extend their debentures for up to two years. A total of 8,444,000 warrants  with an exercise price of  $0.05 per warrant were issued with staggered expiry dates in 2022.

It is BacTech's intention to redeem these debentures either through repayment or conversion into common shares of the Company.

ABOUT BACTECH

BacTech is promoting the use of its proprietary bioleach processing technology to treat historic arsenopyrite concentrates and tailings produced in the Ponce Enriquez area of Southern Ecuador. The Company is also awaiting the reduction in government imposed Covid restrictions in Colombia where BacTech will investigate a gold/platinum tailings project.

For further information contact:

Ross Orr,

President & CEO, BacTech Environmental Corporation

416-813-0303 ext. 222,

Cell 416-346-5529 and

Email: [email protected]

Website: www.bactechgreen.com

Follow us on:

Facebook http://www.facebook.com/BacTechGreen
Twitter
http://twitter.com/BacTechGreen

LinkedIn http://www.linkedin.com/company/1613873
Vimeo
 http://vimeo.com/bactechgreen
YouTube
 http://www.youtube.com/user/bactechgreen

Special Note Regarding Forward-Looking Statements

Shares outstanding: 132,310,538

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the shares, nor is it a solicitation of interest from a prospective investor.

Copyright (c) 2021 TheNewswire - All rights reserved.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.